Facebook Twitter Youtube Vk Rss
Facebook Twitter Youtube Vk Rss
  Trending
Telesis Bio Reports Record Q4 Revenues March 22, 2023
JanOne Sells ARCA Recycling to Focus on Growing BioPharm Businesses March 22, 2023
Vistagen Announces Positive Phase 3 Data March 22, 2023
89bio Reports Positive Phase 2b Results March 22, 2023
Virgin Orbit Reportedly near closing $200 Million Private Placement March 22, 2023
Next
Prev

NASDAQ:IDRA up more than 60% pre-market on positive results!

  • May 17, 2022 at 7:53 AM

(Nasdaq: IDRA) today shared positive interim results from Amsterdam UMC, Vrije Universiteit Amsterdam, the Netherlands, regarding its investigator-sponsored trial, INTRIM 1, involving tilsotolimod, Ideras synthetic Toll-like receptor 9 agonist. Based on these results, the trial has been stopped early.

XTON, Pa., May 17, 2022 (GLOBE NEWSWIRE) — Idera Pharmaceuticals, Inc. (Idera, we, and our) (Nasdaq: IDRA) today shared positive interim results from Amsterdam UMC, Vrije Universiteit Amsterdam, the Netherlands, regarding its investigator-sponsored trial, INTRIM 1, involving tilsotolimod, Ideras synthetic Toll-like receptor 9 agonist. Based on these results, the trial has been stopped early.

https://www.globenewswire.com/news-release/2022/05/17/2444956/33448/en/Idera-Pharmaceuticals-Shares-Positive-Results-from-Investigator-Sponsored-Trial-in-Melanoma-Patients-at-Amsterdam-UMC.html

RelatedNews

Want more news like this? Check out our homepage!

Signup today for free and be the first to get notified of breaking news.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Recent News

Follow Us

Facebook-f Twitter Youtube

SIGN UP FOR OUR NEWSLETTER

Sign up for Breaking Alerts, our newsletter putting timely and updated stock and crypto markets news into your hands.

24/7 MarketNews is a leading market news platform for public companies. As a pioneer in digital media, we are dedicated to the swift distribution of financial market news and information. We take great pride in creating innovative public relations campaigns that help our clients reach their target audience.

Search by keyword

© 2022-2023 24/7MarketNews – The Experts in Investor and Public Relations

Add New Playlist

This website uses cookies. By continuing to use this website you are giving consent to cookies being used. Visit our Privacy and Cookie Policy.